- Home
- AISP vs KRON Comparison
AISP vs KRON Comparison
Compare AISP & KRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AISP
- KRON
- Stock Information
- Founded
- AISP 2006
- KRON 2017
- Country
- AISP United States
- KRON United States
- Employees
- AISP N/A
- KRON N/A
- Industry
- AISP Blank Checks
- KRON Medicinal Chemicals and Botanical Products
- Sector
- AISP Finance
- KRON Health Care
- Exchange
- AISP Nasdaq
- KRON Nasdaq
- Market Cap
- AISP 62.6M
- KRON 60.3M
- IPO Year
- AISP N/A
- KRON 2020
- Fundamental
- Price
- AISP $2.85
- KRON $0.85
- Analyst Decision
- AISP Strong Buy
- KRON Buy
- Analyst Count
- AISP 2
- KRON 3
- Target Price
- AISP $9.00
- KRON $1.63
- AVG Volume (30 Days)
- AISP 1.2M
- KRON 121.3K
- Earning Date
- AISP 11-14-2024
- KRON 11-13-2024
- Dividend Yield
- AISP N/A
- KRON N/A
- EPS Growth
- AISP N/A
- KRON N/A
- EPS
- AISP 0.73
- KRON N/A
- Revenue
- AISP $24,050,308.00
- KRON $9,865,000.00
- Revenue This Year
- AISP $111.47
- KRON $52.58
- Revenue Next Year
- AISP $32.94
- KRON N/A
- P/E Ratio
- AISP $3.89
- KRON N/A
- Revenue Growth
- AISP 148.46
- KRON 146.56
- 52 Week Low
- AISP $1.34
- KRON $0.69
- 52 Week High
- AISP $14.32
- KRON $1.60
- Technical
- Relative Strength Index (RSI)
- AISP 55.37
- KRON 40.22
- Support Level
- AISP $2.08
- KRON $0.83
- Resistance Level
- AISP $4.40
- KRON $0.98
- Average True Range (ATR)
- AISP 0.40
- KRON 0.06
- MACD
- AISP 0.15
- KRON -0.01
- Stochastic Oscillator
- AISP 38.00
- KRON 25.00
About AISP Airship AI Holdings Inc.
Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where they need it, using a highly secure permission-based architecture.
About KRON Kronos Bio Inc.
Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.